Literature DB >> 1648852

Intact parathyroid hormone concentration and cyclic AMP metabolism in thyroid disease.

W D Fraser1, F C Logue, K MacRitchie, R M Wilson, H W Gray, G H Beastall, D S O'Reilly.   

Abstract

In 35 thyrotoxic patients and 35 patients receiving thyroxine replacement therapy mean serum intact parathyroid hormone concentrations were lower than in euthyroid normal volunteer controls. In 20 hypothyroid patients intact PTH was increased relative to euthyroid controls. Mean serum adjusted calcium was increased in thyrotoxic patients relative to euthyroid controls and in 8 toxic patients with elevated serum adjusted calcium (greater than 2.60 mmol/l) intact PTH was below the assay detection limit (less than 0.5 pmol/l). Indices of PTH activity were consistent with intact PTH measurements in thyrotoxic patients with nephrogenous cyclic adenosine monophosphate lower, tubular maximum reabsorption of phosphate higher, and urinary calcium creatinine ratio higher than controls. In hypothyroid patients these indices of PTH activity suggest relative end organ resistance to PTH with nephrogenous cyclic adenosine monophosphate similar, tubular maximum reabsorption of phosphate similar, and calcium creatinine ratio lower than in controls. In treated hypothyroid patients nephrogenous cyclic adenosine monophosphate was higher, tubular maximum reabsorption of phosphate similar, and calcium creatinine ratio higher than in controls. These results are compatible with the hypothesis that thyroid status modifies the renal responses to PTH (1-84).

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1648852     DOI: 10.1530/acta.0.1240652

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  1 in total

1.  Bone mineral metabolism and thyroid replacement therapy in congenital hypothyroid infants and young children.

Authors:  G Weber; S Mora; A Bellini; M Bosco; C Prinster; V Siragusa; B di Natale; G Chiumello
Journal:  J Endocrinol Invest       Date:  1995-04       Impact factor: 4.256

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.